Skip to content

Challenging science. Changing lives.

Amylin Pharmaceuticals is an exceptional company of extraordinary people. Their willingness to challenge conventional thinking as much as they challenge themselves, their resolve, resiliency and passion for the patient are improving the lives of millions.

The men and women of Amylin are discovering, developing, and bringing to market innovative therapies with life-changing potential for people struggling with diabetes and obesity—merging epidemics that are fast becoming the major health crises of our lifetime. In the process, they are building an exciting new franchise in the treatment of metabolic disease and a pipeline of possibilities for future healthcare solutions.

Announcements

News & Events

  • Jul 27

    Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Confere... Full Story

  • Jul 21

    Amylin Pharmaceuticals Reports Second Quarter Financial Results Full Story

  • Jul 14

    Amylin Pharmaceuticals to Webcast Second Quarter Results Full Story

View All

  • Aug 03

    Amylin Pharmaceuticals, Inc. at Wedbush Morgan Securities Life Science... Full Story

  • Jul 21

    Q2 2010 Amylin Pharmaceuticals, Inc. Earnings Conference Call Full Story

  • Jul 21

    Q2 2010 Amylin Pharmaceuticals, Inc. Earnings Release Full Story

View All

Spotlight

Schedule of Selected ADA Presentations
Download PDF

Patients

Investors

Patient Stories Amylin has an ambitious and challenging goal: to change the lives of millions of people living with diabetes. To make that happen, they’ve delivered two first-in-class medicines.
Thumb: Investors Our Investor Relations Center is provided to give you convenient access to company information, including financial reports, press releases and corporate events. You can also sign up to be reminded via email.